Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data

被引：0
|
作者：
Tae-Hwan Kim
Hun Do Cho
Yong Won Choi
Hyun Woo Lee
Seok Yun Kang
Geum Sook Jeong
Jin-Hyuk Choi
Mi Sun Ahn
Seung-Soo Sheen
机构：
[1] Ajou University School of Medicine,Department of Hematology
[2] Ajou University School of Medicine,Oncology
来源：
BMC Cancer | / 21卷
关键词：
Trastuzumab; Chemotherapy; Gastric cancer; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
    Kim, Tae-Hwan
    Do Cho, Hun
    Choi, Yong Won
    Lee, Hyun Woo
    Kang, Seok Yun
    Jeong, Geum Sook
    Choi, Jin-Hyuk
    Ahn, Mi Sun
    Sheen, Seung-Soo
    BMC CANCER, 2021, 21 (01)
  • [2] Pathologic Response of HER2-positive Gastric Cancer to Trastuzumab-based Chemotherapy
    Urabe, Masayuki
    Ushiku, Tetsuo
    Seto, Yasuyuki
    Fukayama, Masashi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (10) : 1326 - 1333
  • [3] Trastuzumab-based treatment of HER2-positive metastatic gastric cancer
    Dogan, I.
    Karabulut, S.
    Tastekin, D.
    Paksoy, N.
    Sakar, B.
    Vatansever, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S205 - S205
  • [4] Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study
    Q. Li
    H. Li
    H. Jiang
    Y. Feng
    Y. Cui
    Y. Wang
    Y. Ji
    Y. Yu
    W. Li
    C. Xu
    S. Yu
    R. Zhuang
    T. Liu
    Clinical and Translational Oncology, 2018, 20 : 695 - 702
  • [5] Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study
    Li, Q.
    Li, H.
    Jiang, H.
    Feng, Y.
    Cui, Y.
    Wang, Y.
    Ji, Y.
    Yu, Y.
    Li, W.
    Xu, C.
    Yu, S.
    Zhuang, R.
    Liu, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 695 - 702
  • [6] PROGNOSTIC IMPACT OF HER2 IMMUNOREACTIVITY IN HER2-POSITIVE GASTRIC CANCER TREATED WITH TRASTUZUMAB-BASED CHEMOTHERAPY
    Kadowaki, Shigenori
    Narita, Yukiya
    Komori, Azusa
    Nomura, Motoo
    Taniguchi, Hiroya
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Niwa, Yasumasa
    Muro, Kei
    ANNALS OF ONCOLOGY, 2014, 25
  • [7] Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study
    Shoko Marshall
    Takeru Wakatsuki
    Daisuke Takahari
    Tomohiro Matsushima
    Naoki Ishizuka
    Izuma Nakayama
    Hiroki Osumi
    Mariko Ogura
    Takashi Ichimura
    Eiji Shinozaki
    Keisho Chin
    Kensei Yamaguchi
    Journal of Gastrointestinal Cancer, 2023, 54 : 475 - 484
  • [8] Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study
    Marshall, Shoko
    Wakatsuki, Takeru
    Takahari, Daisuke
    Matsushima, Tomohiro
    Ishizuka, Naoki
    Nakayama, Izuma
    Osumi, Hiroki
    Ogura, Mariko
    Ichimura, Takashi
    Shinozaki, Eiji
    Chin, Keisho
    Yamaguchi, Kensei
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 475 - 484
  • [9] Real-World data of triplet combination of trastuzumab, lapatinib and chemotherapy in HER2-positive metastatic breast cancer: A multi-center retrospective study
    Li, Y.
    Gong, C.
    Lu, Q.
    Zhou, Z.
    Luo, T.
    Li, W.
    Li, G.
    Ge, R.
    Wang, B.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S66 - S66
  • [10] Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center
    Piezzo, Michela
    D'Aniello, Roberta
    Avallone, Ilaria
    Barba, Bruno
    Cianniello, Daniela
    Cocco, Stefania
    D'Avino, Antonio
    Di Gioia, Germira
    Di Lauro, Vincenzo
    Fusco, Giuseppina
    Piscitelli, Raffaele
    von Arx, Claudia
    De Laurentiis, Michelino
    Maiolino, Piera
    PHARMACEUTICS, 2021, 13 (05)
12345